Regeneron plots $40M expansion, 400 new hires

New York-based Regeneron is blueprinting plans for a $40 million expansion of its facilities, paving the way for the developer to add 400 new jobs--primarily in research. One hundred of those positions will be in East Greenbush, while 300 hires are planned for its Westchester County complex.

As part of its expansion, Regeneron is upgrading a 131,000-square-foot building--the third research facility it has in Tarrytown. The biotech company recently completed two new facilities on the site. Regeneron has been on a roll recently; about a month ago, the biotech announced that Sanofi-Aventis had expanded its research partnership, committing to pay Regeneron more than a billion dollars over eight years.

"Because we have the type of business where we are moving product candidates through the pipeline, in the beginning we will need people who do the research," a spokesperson tells the Albany Business Review, adding that once drug candidates are approved, "we will need people on the other end in Rensselaer."

- here's the report from the Business Review

Suggested Articles

Genor Biopharma banked $160 million from the likes of Hillhouse and Temasek Holdings to advance its clinical-stage autoimmune and cancer programs.

Going from being the CSO of Bristol Myers Squibb to running one of the biggest cancer research organizations in the world is a major career shift.

Hahn made the commitment in a speech that called on the FDA to learn from the crisis to enact lasting policies that accelerate drug development.